Sign In
Buy MRK
$119.05
-1.73 (-1.43%)
At Close: Jun 12, 2026
2 Dirt Cheap Stocks to Buy With $200 Right Now
09:01am, Saturday, 24'th Jan 2026
CVS Health rebounded last year, but there is plenty of upside left given ongoing developments. Merck is slowly crafting a strategy to overcome increased competition for its biggest cash cow.
2 Soaring Stocks to Hold for the Next 20 Years
12:30pm, Friday, 23'rd Jan 2026
These companies have resilient businesses that can navigate challenges. Both are great dividend-paying stocks.
VanEck Pharmaceutical Fund Bets Big on Weight-Loss Drug Market Approaching $150 Billion
10:36am, Friday, 23'rd Jan 2026
The VanEck Pharmaceutical ETF (NYSEARCA:PPH) has surged 26% over the past year, driven almost entirely by the weight-loss drug revolution. The fund's concentrated bet on GLP-1 manufacturers makes this
I Correctly Predicted That These 15 Dow Jones Stocks Would Boost Their Payouts in 2025. Here's Why It Can Happen Again in 2026.
02:15pm, Thursday, 22'nd Jan 2026
The Dow is chock-full of high-quality companies that pay growing dividends.
ABBV vs. MRK: An Oncology-Immunology Showdown for Investors
01:05pm, Thursday, 22'nd Jan 2026
ABBV has rebounded after Humira patent cliff, with Skyrizi and Rinvoq driving growth. Rising estimates and a pipeline set to power earnings into 2029 bode well.
MRNA & MRK's Personalized Cancer Therapy Delivers Strong 5-Year Data
12:40pm, Thursday, 22'nd Jan 2026
Moderna rises after five-year phase IIb data show the combo of intismeran autogene plus Keytruda cuts recurrence or death risk by 49% in high-risk melanoma.
Stock Market Today: S&P 500, Dow Jones Futures Rise As Trump Scales Down EU Tariff Threats—Microsoft, Moderna, Intel In Focus
05:19am, Thursday, 22'nd Jan 2026
U.S. stock futures rose on Thursday following Wednesday's gains. Futures of major benchmark indices were higher.
Top 10 Dividend Stocks For Uncertain Times
05:00am, Thursday, 22'nd Jan 2026
Stocks entered 2026 on a positive note before a global sell-off wiped out gains, driven by tariff tensions, a Greenland tug-of-war, and Japan's bond crisis. In this uncertain environment, dividends ca
Bailard Inc. Sells 30,041 Shares of Merck & Co., Inc. $MRK
03:41am, Thursday, 22'nd Jan 2026
Bailard Inc. lowered its holdings in Merck and Co., Inc. (NYSE: MRK) by 50.8% in the undefined quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor
Merck (MRK) Rises Higher Than Market: Key Facts
06:50pm, Wednesday, 21'st Jan 2026
Merck (MRK) concluded the recent trading session at $111.11, signifying a +1.52% move from its prior day's close.
Merck partners with global health coalition to develop affordable Ebola vaccine
11:01am, Wednesday, 21'st Jan 2026
Merck and the Coalition for Epidemic Preparedness Innovations said on Wednesday they have partnered on a $30 million program to develop an updated version of the drugmaker's Ebola vaccine aimed at imp
Dynasty Wealth Management LLC Takes $1.02 Million Position in Merck & Co., Inc. $MRK
04:43am, Wednesday, 21'st Jan 2026
Dynasty Wealth Management LLC bought a new position in shares of Merck and Co., Inc. (NYSE: MRK) in the third quarter, according to its most recent filing with the Securities and Exchange Commission.
Market Today: Netflix's WBD Bid, Tech Selloff, AI at Davos
05:35pm, Tuesday, 20'th Jan 2026
Guru Stock PicksChuck Royce has made the following transactions:Reduce in APYX by 1.27%Add in EBF by 4.13%New position in ANDGSmead Value Fund has made the foll
Will Weak Gardasil Sales Continue to Ail MRK Revenues in Q4 Earnings?
09:51am, Tuesday, 20'th Jan 2026
Gardasil's sharp sales slump in China and Japan puts Merck under pressure heading into Q4 earnings, with the vaccine's sales expected to stay under strain.
Moderna, Merck Report Positive Results From Cancer-Vaccine Study
06:58am, Tuesday, 20'th Jan 2026
Moderna and Merck's cancer vaccine reduced the risk of relapse or death for melanoma patients, five-year data from a Phase 2b trial showed.
